[논문]Comparison of Antiviral Activity of Gemcitabine with 2′-Fluoro-2′-Deoxycytidine and Combination Therapy with Remdesivir against SARS-CoV-2

Jang, Yejin; Shin, Jin Soo; Lee, Myoung Kyu; Jung, Eunhye; An, Timothy; Kim, Uk-Il; Kim, Kyungjin; Kim, Meehyein

doi:10.3390/ijms22041581

[해외논문] Comparison of Antiviral Activity of Gemcitabine with 2′-Fluoro-2′-Deoxycytidine and Combination Therapy with Remdesivir against SARS-CoV-2 원문보기

International journal of molecular sciences, v.22 no.4, 2021년, pp.1581 -

Jang, Yejin (Infectious Diseases Therapeutic Research Center, Korea Research Institute of Chemical Technology (KRICT), Daejeon 34114, Korea) , Shin, Jin Soo (erythro1@krict.re.kr (Y.J.)) , Lee, Myoung Kyu (jsshin@krict.re.kr (J.S.S.)) , Jung, Eunhye (lmg1671@krict.re.kr (M.K.L.)) , An, Timothy (ehjung@krict.re.kr (E.J.)) , Kim, Uk-Il (timothy@krict.re.kr (T.A.)) , Kim, Kyungjin (Infectious Diseases Therapeutic Research Center, Korea Research Institute of Chemical Technology (KRICT), Daejeon 34114, Korea) , Kim, Meehyein (erythro1@krict.re.kr (Y.J.))

Abstract ▼ AI-Helper

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of the coronavirus disease 2019 (COVID-19) pandemic. The virus still spreads globally through human-to-human transmission. Nevertheless, there are no specific treatments clinically approved. This study aimed to compare antiviral activity of gemcitabine and its analogue 2′-fluoro-2′-deoxycytidine (2FdC) against SARS-CoV-2 as well as cytotoxicity in vitro. Fluorescent image-based antiviral assays revealed that gemcitabine was highly potent, with a 50% effective concentration (EC50) of 1.2 μM, more active than the well-known nucleoside monophosphate remdesivir (EC50 = 35.4 μM). In contrast, 2FdC was marginally active (EC50 = 175.2 μM). For all three compounds, the 50% cytotoxic concentration (CC50) values were over 300 μM toward Vero CCL-81 cells. Western blot and quantitative reverse-transcription polymerase chain reaction analyses verified that gemcitabine blocked viral protein expression in virus-infected cells, not only Vero CCL-81 cells but also Calu-3 human lung epithelial cells in a dose-dependent manner. It was found that gemcitabine has a synergistic effect when combined with remdesivir. This report suggests that the difluoro group of gemcitabine is critical for the antiviral activity and that its combination with other evaluated antiviral drugs, such as remdesivir, could be a desirable option to treat SARS-CoV-2 infection.

Keyword

참고문헌 (41)

1. Maters P.S. Perlman S. Coronaviridae Fields Virology Knife D.M. Howley P.M. Lippincott Williams and Wilkins Philadelphia, PA, USA 2013 Volume 2 825 858
2. Song Z. Xu Y. Bao L. Zhang L. Yu P. Qu Y. Zhu H. Zhao W. Han Y. Qin C. From SARS to MERS, Thrusting Coronaviruses into the Spotlight Viruses 2019 11 50 10.3390/v11010059

상세보기
3. Wu A. Peng Y. Huang B. Ding X. Wang X. Niu P. Meng J. Zhu Z. Zhang Z. Wang J. Genome Composition and Divergence of the Novel Coronavirus (2019-nCoV) Originating in China Cell Host Microbe 2020 27 325 328 10.1016/j.chom.2020.02.001 32035028

상세보기
4. Wang D. Hu B. Hu C. Zhu F. Liu X. Zhang J. Wang B. Xiang H. Cheng Z. Xiong Y. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China JAMA 2020 323 1061 1069 10.1001/jama.2020.1585 32031570

상세보기
5. Zhu N. Zhang D. Wang W. Li X. Yang B. Song J. Zhao X. Huang B. Shi W. Lu R. A Novel Coronavirus from Patients with Pneumonia in China, 2019 N. Engl. J. Med. 2020 382 727 733 10.1056/NEJMoa2001017 31978945

상세보기
6. Jeon S. Ko M. Lee J. Choi I. Byun S.Y. Park S. Shum D. Kim S. Identification of Antiviral Drug Candidates against SARS-CoV-2 from FDA-Approved Drugs Antimicrob. Agents Chemother. 2020 64 e00819-20 10.1128/AAC.00819-20 32366720

상세보기
7. Wang M. Cao R. Zhang L. Yang X. Liu J. Xu M. Shi Z. Hu Z. Zhong W. Xiao G. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro Cell Res. 2020 30 269 271 10.1038/s41422-020-0282-0 32020029

상세보기
8. Hoffmann M. Kleine-Weber H. Schroeder S. Kruger N. Herrler T. Erichsen S. Schiergens T.S. Herrler G. Wu N.H. Nitsche A. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor Cell 2020 181 271 280.e8 10.1016/j.cell.2020.02.052 32142651

상세보기
9. Hoffmann M. Kleine-Weber H. Pohlmann S. A Multibasic Cleavage Site in the Spike Protein of SARS-CoV-2 Is Essential for Infection of Human Lung Cells Mol. Cell 2020 78 779 784.e5 10.1016/j.molcel.2020.04.022 32362314

상세보기
10. Shang J. Wan Y. Luo C. Ye G. Geng Q. Auerbach A. Li F. Cell entry mechanisms of SARS-CoV-2 Proc. Natl. Acad. Sci. USA 2020 117 11727 11734 10.1073/pnas.2003138117 32376634

상세보기
11. Xia S. Liu M. Wang C. Xu W. Lan Q. Feng S. Qi F. Bao L. Du L. Liu S. Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion Cell Res. 2020 30 343 355 10.1038/s41422-020-0305-x 32231345

상세보기
12. Subissi L. Posthuma C.C. Collet A. Zevenhoven-Dobbe J.C. Gorbalenya A.E. Decroly E. Snijder E.J. Canard B. Imbert I. One severe acute respiratory syndrome coronavirus protein complex integrates processive RNA polymerase and exonuclease activities Proc. Natl. Acad. Sci. USA 2014 111 E3900 E3909 10.1073/pnas.1323705111 25197083

상세보기
13. Gao Y. Yan L. Huang Y. Liu F. Zhao Y. Cao L. Wang T. Sun Q. Ming Z. Zhang L. Structure of the RNA-dependent RNA polymerase from COVID-19 virus Science 2020 368 779 782 10.1126/science.abb7498 32277040

상세보기
14. Hillen H.S. Kokic G. Farnung L. Dienemann C. Tegunov D. Cramer P. Structure of replicating SARS-CoV-2 polymerase Nature 2020 584 154 156 10.1038/s41586-020-2368-8 32438371

상세보기
15. Wang Q. Wu J. Wang H. Gao Y. Liu Q. Mu A. Ji W. Yan L. Zhu Y. Zhu C. Structural Basis for RNA Replication by the SARS-CoV-2 Polymerase Cell 2020 182 417 428.e13 10.1016/j.cell.2020.05.034 32526208

상세보기
16. Shin J.S. Jung E. Kim M. Baric R.S. Go Y.Y. Saracatinib Inhibits Middle East Respiratory Syndrome-Coronavirus Replication In Vitro Viruses 2018 10 283 10.3390/v10060283

상세보기
17. Denisova O.V. Kakkola L. Feng L. Stenman J. Nagaraj A. Lampe J. Yadav B. Aittokallio T. Kaukinen P. Ahola T. Obatoclax, saliphenylhalamide, and gemcitabine inhibit influenza a virus infection J. Biol. Chem. 2012 287 35324 35332 10.1074/jbc.M112.392142 22910914

상세보기
18. Kuivanen S. Bespalov M.M. Nandania J. Ianevski A. Velagapudi V. De Brabander J.K. Kainov D.E. Vapalahti O. Obatoclax, saliphenylhalamide and gemcitabine inhibit Zika virus infection in vitro and differentially affect cellular signaling, transcription and metabolism Antivir. Res. 2017 139 117 128 10.1016/j.antiviral.2016.12.022 28049006

상세보기
19. Gayral M. Lulka H. Hanoun N. Biollay C. Selves J. Vignolle-Vidoni A. Berthomme H. Trempat P. Epstein A.L. Buscail L. Targeted oncolytic herpes simplex virus type 1 eradicates experimental pancreatic tumors Hum. Gene Ther. 2015 26 104 113 10.1089/hum.2014.072 25423447

상세보기
20. Zhang Y.N. Zhang Q.Y. Li X.D. Xiong J. Xiao S.Q. Wang Z. Zhang Z.R. Deng C.L. Yang X.L. Wei H.P. Gemcitabine, lycorine and oxysophoridine inhibit novel coronavirus (SARS-CoV-2) in cell culture Emerg. Microbes Infect. 2020 9 1170 1173 10.1080/22221751.2020.1772676 32432977

상세보기
21. Smee D.F. Jung K.H. Westover J. Gowen B.B. 2′-Fluoro-2′-deoxycytidine is a broad-spectrum inhibitor of bunyaviruses in vitro and in phleboviral disease mouse models Antivir. Res. 2018 160 48 54 10.1016/j.antiviral.2018.10.013 30339848

상세보기
22. Kumaki Y. Day C.W. Smee D.F. Morrey J.D. Barnard D.L. In vitro and in vivo efficacy of fluorodeoxycytidine analogs against highly pathogenic avian influenza H5N1, seasonal, and pandemic H1N1 virus infections Antivir. Res. 2011 92 329 340 10.1016/j.antiviral.2011.09.001 21925541

상세보기
23. Petersen E. Koopmans M. Go U. Hamer D.H. Petrosillo N. Castelli F. Storgaard M. Khalili S.A. Simonsen L. Comparing SARS-CoV-2 with SARS-CoV and influenza pandemics Lancet Infect. Dis. 2020 20 e238 e244 10.1016/S1473-3099(20)30484-9 32628905

상세보기
24. Tay M.Z. Poh C.M. Renia L. MacAry P.A. Ng L.F.P. The trinity of COVID-19: Immunity, inflammation and intervention Nat. Rev. Immunol. 2020 20 363 374 10.1038/s41577-020-0311-8 32346093

상세보기
25. Veltkamp S.A. Pluim D. van Eijndhoven M.A. Bolijn M.J. Ong F.H. Govindarajan R. Unadkat J.D. Beijnen J.H. Schellens J.H. New insights into the pharmacology and cytotoxicity of gemcitabine and 2′,2′-difluorodeoxyuridine Mol. Cancer Ther. 2008 7 2415 2425 10.1158/1535-7163.MCT-08-0137 18723487

상세보기
26. Baker C.H. Banzon J. Bollinger J.M. Stubbe J. Samano V. Robins M.J. Lippert B. Jarvi E. Resvick R. 2′-Deoxy-2′-methylenecytidine and 2′-deoxy-2′,2′-difluorocytidine 5′-diphosphates: Potent mechanism-based inhibitors of ribonucleotide reductase J. Med. Chem. 1991 34 1879 1884 10.1021/jm00110a019 2061926

상세보기
27. Huang P. Chubb S. Hertel L.W. Grindey G.B. Plunkett W. Action of 2′,2′-difluorodeoxycytidine on DNA synthesis Cancer Res. 1991 51 6110 6117 1718594

상세보기
28. Giovannetti E. Mey V. Loni L. Nannizzi S. Barsanti G. Savarino G. Ricciardi S. Del Tacca M. Danesi R. Cytotoxic activity of gemcitabine and correlation with expression profile of drug-related genes in human lymphoid cells Pharmacol. Res. 2007 55 343 349 10.1016/j.phrs.2007.01.003 17296311

상세보기
29. Kim M. Kim S.Y. Lee H.W. Shin J.S. Kim P. Jung Y.S. Jeong H.S. Hyun J.K. Lee C.K. Inhibition of influenza virus internalization by (-)-epigallocatechin-3-gallate Antivir. Res. 2013 100 460 472 10.1016/j.antiviral.2013.08.002 23954192

상세보기
30. Jang K.J. Jeong S. Kang D.Y. Sp N. Yang Y.M. Kim D.E. A high ATP concentration enhances the cooperative translocation of the SARS coronavirus helicase nsP13 in the unwinding of duplex RNA Sci. Rep. 2020 10 4481 10.1038/s41598-020-61432-1 32161317

상세보기
31. Hou Y.J. Okuda K. Edwards C.E. Martinez D.R. Asakura T. Dinnon K.H. 3rd Kato T. Lee R.E. Yount B.L. Mascenik T.M. SARS-CoV-2 Reverse Genetics Reveals a Variable Infection Gradient in the Respiratory Tract Cell 2020 182 429 446.e14 10.1016/j.cell.2020.05.042 32526206

상세보기
32. Kang H. Kim C. Kim D.E. Song J.H. Choi M. Choi K. Kang M. Lee K. Kim H.S. Shin J.S. Synergistic antiviral activity of gemcitabine and ribavirin against enteroviruses Antivir. Res. 2015 124 1 10 10.1016/j.antiviral.2015.10.011 26526589

상세보기
33. Heinemann V. Schulz L. Issels R.D. Plunkett W. Gemcitabine: A modulator of intracellular nucleotide and deoxynucleotide metabolism Semin. Oncol. 1995 22 11 18 7481839

상세보기
34. Pruijssers A.J. George A.S. Schafer A. Leist S.R. Gralinksi L.E. Dinnon K.H. 3rd Yount B.L. Agostini M.L. Stevens L.J. Chappell J.D. Remdesivir Inhibits SARS-CoV-2 in Human Lung Cells and Chimeric SARS-CoV Expressing the SARS-CoV-2 RNA Polymerase in Mice Cell Rep. 2020 32 107940 10.1016/j.celrep.2020.107940 32668216

상세보기
35. Mumtaz N. Jimmerson L.C. Bushman L.R. Kiser J.J. Aron G. Reusken C. Koopmans M.P.G. van Kampen J.J.A. Cell-line dependent antiviral activity of sofosbuvir against Zika virus Antivir. Res. 2017 146 161 163 10.1016/j.antiviral.2017.09.004 28912011

상세보기
36. Wu W. Sigmond J. Peters G.J. Borch R.F. Synthesis and biological activity of a gemcitabine phosphoramidate prodrug J. Med. Chem. 2007 50 3743 3746 10.1021/jm070269u 17602464

상세보기
37. Kumar V. Shin J.S. Shie J.J. Ku K.B. Kim C. Go Y.Y. Huang K.F. Kim M. Liang P.H. Identification and evaluation of potent Middle East respiratory syndrome coronavirus (MERS-CoV) 3CL(Pro) inhibitors Antivir. Res. 2017 141 101 106 10.1016/j.antiviral.2017.02.007 28216367

상세보기
38. Siegel D. Hui H.C. Doerffler E. Clarke M.O. Chun K. Zhang L. Neville S. Carra E. Lew W. Ross B. Discovery and Synthesis of a Phosphoramidate Prodrug of a Pyrrolo[2,1-f][triazin-4-amino] Adenine C-Nucleoside (GS-5734) for the Treatment of Ebola and Emerging Viruses J. Med. Chem. 2017 60 1648 1661 10.1021/acs.jmedchem.6b01594 28124907

상세보기
39. Jang Y. Shin J.S. Yoon Y.S. Go Y.Y. Lee H.W. Kwon O.S. Park S. Park M.S. Kim M. Salinomycin Inhibits Influenza Virus Infection by Disrupting Endosomal Acidification and Viral Matrix Protein 2 Function J. Virol. 2018 92 e01441-18 10.1128/JVI.01441-18 30282713

상세보기
40. Softic L. Brillet R. Berry F. Ahnou N. Nevers Q. Morin-Dewaele M. Hamadat S. Bruscella P. Fourati S. Pawlotsky J.M. Inhibition of SARS-CoV-2 Infection by the Cyclophilin Inhibitor Alisporivir (Debio 025) Antimicrob. Agents Chemother. 2020 64 e00876-20 10.1128/AAC.00876-20 32376613

상세보기
41. Fivelman Q.L. Adagu I.S. Warhurst D.C. Modified fixed-ratio isobologram method for studying in vitro interactions between atovaquone and proguanil or dihydroartemisinin against drug-resistant strains of Plasmodium falciparum Antimicrob. Agents Chemother. 2004 48 4097 4102 10.1128/AAC.48.11.4097-4102.2004 15504827

상세보기

LOADING...

활용도 분석정보

상세보기

다운로드

내보내기

활용도 Top5 논문

해당 논문의 주제분야에서 활용도가 높은 상위 5개 콘텐츠를 보여줍니다.
더보기 버튼을 클릭하시면 더 많은 관련자료를 살펴볼 수 있습니다.

표제어: PCR

동의어: Packet Collision Rate

용어 설명 출처 목록 (6)

용어 설명: PCR은 세균 특이성이 있는 primer를 이용하여 적은 수의 세균이 있을지라도 쉽게 검출할 수 있는 유용한 방법이며, 이를 이용하여 구강 내 치면세균막이나 타액에서 직접 세균을 검출할 수 있게 되었다[8].

내보내기 구분	파일저장 인쇄 메일전송
구성항목	기본정보 상세정보 관리번호, 논문명, 저널/프로시딩명, 저자 , 발행년, 권, 호, 시작페이지, 끝페이지, 발행기관 관리번호, 논문명, 대등논문명, 저자 , 저널/프로시딩명, 발행기관, 발행년, 발행언어, 권, 호, 시작페이지, 끝페이지, ISBN, ISSN, 주제분야, 키워드, 초록(한글), 초록(영문), 저자(소속기관)
저장형식	Text(ASCII format) Excel format RefWorks Direct Export RIS format (for Reference Manager, ProCite, EndNote), Scholar's Aids, Mendeley
메일정보	받는사람 (필수) @ 보내는사람 (선택) @ 제목 내용 KISTI 검색결과 이메일 서비스
안내	총 건의 자료가 검색되었습니다. 다운받으실 자료의 인덱스를 입력하세요. (1-10,000) 검색결과의 순서대로 최대 10,000건 까지 다운로드가 가능합니다. 데이타가 많을 경우 속도가 느려질 수 있습니다.(최대 2~3분 소요) 다운로드 파일은 UTF-8 형태로 저장됩니다. 파일의 내용이 제대로 보이지 않을실 때는 웹브라우저 상단의 보기 -> 인코딩 -> 자동선택 여부를 확인하십시오. ~ Text(ASCII format) Excel format

연합인증